Yong'an makes use of resource advantages to build a natural plant pharmaceutical base in the west of the sea

On October 12, workers in the workshop of Fujian Kehong Bioengineering Co., Ltd were operating the sucralose dryer carefully The company has 6 production lines of sucralose with an annual output of 500 tons, with a total investment of 12000 yuan At present, two production lines in phase I of the project have been completed and put into operation, with a total investment of 65 million yuan After the project is completed and put into operation, the new output value will be 300 million yuan, and the tax revenue will be 15 million yuan, becoming the leading enterprise of domestic sucralose production Kehong Bioengineering Co., Ltd is the key enterprise of Yong'an biomedicine In recent years, the city has listed biomedicine as an emerging industry of "5 + 2" key sustainable development Focusing on the goal of building a natural plant pharmaceutical base on the west coast of the Straits, the city has developed the planting of medicinal materials according to local conditions, based on the advantages of rich forest resources and biodiversity in the territory, docked with the introduction of biological pharmaceutical processing technology, built on the basis of the planting of medicinal materials, and focused on the processing and extraction of natural medicines Bio pharmaceutical industry cluster At present, the city has built a new biological medicine base with an area of 9690 mu It has many biomedical enterprises with initial scale, such as semeida biotechnology company, tianqijian jinlianlian ecological industry company, Yong'an huangnijia company, Kehong bioengineering company, Lianhuashan natural flavor company, etc In terms of project construction, the city promotes the sound development of biomedical industry by encouraging independent innovation of enterprises and increasing investment in science and technology At present, with a total investment of 100 million yuan, semeida biotechnology company has built a production line project of 10000 mu of mutual leaf and 100 thousand layers of raw material forest planting base and its series of products processing, with an investment of 50 million yuan Six production lines have been put into operation, with an annual output of 300 tons of tea tree oil and an output value of more than 100 million yuan Yongan biomedical industry and storage logistics development project with a total investment of 135 million yuan mainly constructs biomedical industry The production base of characteristic products, biomedical exhibition hall, storage and logistics transfer and supporting facilities, etc have completed an investment of 25 million yuan; the first phase of the deep processing project of tianqijian jinlianian series products has been successfully completed and put into operation, with an investment of 50 million yuan, and the preliminary work of the second phase of the planning and construction is currently being done; Fujian Shanhai Biochemical Technology Co., Ltd and China during June 18 this year The Institute of forest products and chemical industry of the Academy of forestry carried out technical docking and cooperative development, with a total investment of 55 million yuan, and the flavonoid extraction project progressed smoothly.